Keyphrases
Trial Population
100%
Randomized Controlled Trial
100%
Chronic Liver Disease
100%
Brain Volume
100%
Cognitive Impairment
42%
Hypertension
42%
Dallas
42%
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
42%
Systolic Blood Pressure Intervention Trial (SPRINT)
42%
Diabetes
28%
Brain Imaging
28%
Imaging Marker
28%
Linear Regression
14%
Non-associated
14%
Patients with Diabetes
14%
NHLBI
14%
Cognitive Performance
14%
Diabetic
14%
Liver Disease
14%
Cognitive Tests
14%
Non-alcoholic Fatty Liver Disease (NAFLD)
14%
Hypertensive
14%
Brain Magnetic Resonance Imaging
14%
Coordinating Center
14%
Cognitive Dementia
14%
Study within a Trial
14%
Volume Measurement
14%
Medicine and Dentistry
Randomized Controlled Trial
100%
Chronic Liver Disease
100%
Diabetes
85%
Cardiovascular Risk
42%
Intervention Trial
42%
Systolic Blood Pressure
42%
Cognitive Defect
42%
Steatosis
42%
Brain Imaging
28%
Magnetic Resonance Imaging
14%
Diabetes Mellitus
14%
Linear Regression Analysis
14%
Liver Disease
14%
Post-Hoc Analysis
14%
Non-Alcoholic Fatty Liver Disease
14%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Chronic Liver Disease
100%
Cardiovascular Risk
42%
Cognitive Defect
42%
Steatosis
42%
Intervention Trial
42%
Diabetes Mellitus
14%
Liver Disease
14%